ITGAM and acute myeloid leukemia: In contrast, the number of CD11b+/cleaved caspase-3+ cells was increased dose-dependently by radotinib in total populations of Kasumi-1 cells (Fig 6C) and BMCs (AML-3, Fig 6D).